DelveInsight Blog
Related Article
![Pharma News for BeiGene, GSK, Sandoz, Travere Pharma News for BeiGene, GSK, Sandoz, Travere](https://assets.delveinsight.com/blog/wp-content/uploads/2024/03/12161410/pharma-news-for-beigene-gsk-sandoz-travere.png)
BeiGene’s BRUKINSA Gets FDA Accelerated Approval; GSK’s Positive Results in DREAMM-8 Phase III; Sandoz’s Denosumab Biosimilars FDA Approved; Terns Pharma’s TERN-701 Receives Orphan Drug Designation; Wegovy® Approved in US for Overweight Cardiovascular Risk; Travere Therapeutics Submits sNDA for FILSPARI IgAN Full Approval
BeiGene Receives FDA Accelerated Approval for BRUKINSA in Relapsed/Refractory Follicular Lymphoma BeiGene, Ltd., has declared that the FDA has provided accelerated approval for BRUKINSA® (zanubrutinib) to be used in treating adult patients with relapsed or refractory (R/R) follicular lymphoma (FL), when used alo...
Find More![Biosurgery Market Analysis Biosurgery Market Analysis](https://assets.delveinsight.com/blog/wp-content/uploads/2023/09/13154524/biosurgery-market-analysis.webp)
Biosurgery: Advancing Medicine through Biologically Derived Solutions
In recent years, the healthcare and medical devices market has undergone a remarkable transformation, largely fueled by advancements in technology and growth in innovation. One of the major standout developments in the healthcare industry is the rise of the biosurgery market and the related product demand, whic...
Find More![Pacemakers Market and Assessment of Trends, Developments, Growth Pacemakers Market and Assessment of Trends, Developments, Growth](https://assets.delveinsight.com/blog/wp-content/uploads/2023/02/15174147/Pacemakers-Market-and-Assessment-of-Trends-Developments-Growth.png)
Pacemakers: Analyzing the Market Dynamics and Major Developments
Over the past few decades, the prevalence of cardiovascular diseases has grown significantly, leading to very high mortality and morbidity worldwide. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other condition...
Find MoreEditor's Pick
Newsletter/Whitepaper
Recent Article
ASCO Conference 2024
![ASCO 2023 ASCO 2023](https://assets.delveinsight.com/img/events/american-society-of-clinical-oncology-conference-2024.png)
Live Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!